IMUNImmune Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$7,871.00
Vol2.00

About

Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immune Therapeutics Inc?
What is the 52-week high for Immune Therapeutics Inc?
What is the 52-week low for Immune Therapeutics Inc?
What is Immune Therapeutics Inc stock price today?
What was Immune Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Immune Therapeutics Inc?

Latest IMUN News

View
Top Discussions

Advertisement|Remove ads.